Total Payments
$1,240
2024 Payments
$53.15
Companies
17
Transactions
82
Medicare Patients
5,866
Medicare Billing
$571,842
Payment Breakdown by Category
Food & Beverage$1,218 (98.2%)
Education$22.40 (1.8%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,218 | 80 | 98.2% |
| Education | $22.40 | 2 | 1.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $415.86 | 31 | $0 (2024) |
| Astellas Pharma US Inc | $157.80 | 8 | $0 (2021) |
| AstraZeneca Pharmaceuticals LP | $150.69 | 10 | $0 (2021) |
| GlaxoSmithKline, LLC. | $95.07 | 7 | $0 (2023) |
| Amarin Pharma Inc. | $86.37 | 4 | $0 (2018) |
| PFIZER INC. | $77.16 | 6 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $46.98 | 3 | $0 (2019) |
| Amgen Inc. | $39.35 | 2 | $0 (2019) |
| SANOFI-AVENTIS U.S. LLC | $35.29 | 2 | $0 (2018) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $29.81 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $53.15 | 3 | Novo Nordisk Inc ($20.88) |
| 2023 | $143.76 | 8 | Novo Nordisk Inc ($70.62) |
| 2021 | $94.36 | 6 | AstraZeneca Pharmaceuticals LP ($47.25) |
| 2020 | $25.10 | 2 | Novo Nordisk Inc ($13.21) |
| 2019 | $159.41 | 11 | Novo Nordisk Inc ($45.71) |
| 2018 | $440.65 | 26 | Astellas Pharma US Inc ($101.46) |
| 2017 | $323.96 | 26 | Novo Nordisk Inc ($176.38) |
All Payment Transactions
82 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/30/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $20.88 | General |
| 05/01/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $14.84 | General |
| Category: VACCINES | ||||||
| 02/26/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $17.43 | General |
| Category: Diabetes | ||||||
| 12/13/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $15.78 | General |
| Category: Diabetes | ||||||
| 11/15/2023 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $18.05 | General |
| 11/02/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $29.81 | General |
| Category: DIABETES | ||||||
| 10/11/2023 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $14.17 | General |
| Category: VACCINES | ||||||
| 09/27/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $15.86 | General |
| Category: RESPIRATORY | ||||||
| 09/27/2023 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $15.81 | General |
| 08/02/2023 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $20.98 | General |
| 04/17/2023 | Otsuka America Pharmaceutical, Inc. | NUEDEXTA (Drug) | Food and Beverage | In-kind items and services | $13.30 | General |
| Category: NEUROLOGY | ||||||
| 10/20/2021 | Sunovion Pharmaceuticals Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $16.80 | General |
| Category: UROLOGY | ||||||
| 06/17/2021 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $15.16 | General |
| 04/28/2021 | Astellas Pharma US Inc | MYRBETRIQ (Drug) | Food and Beverage | In-kind items and services | $16.46 | General |
| Category: UROLOGY | ||||||
| 04/28/2021 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $13.85 | General |
| 04/13/2021 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $16.64 | General |
| 02/11/2021 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Education | In-kind items and services | $15.45 | General |
| Category: Respiratory | ||||||
| 10/21/2020 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $11.89 | General |
| 05/01/2020 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $13.21 | General |
| Category: Diabetes | ||||||
| 06/19/2019 | Novo Nordisk Inc | Tresiba (Drug), Victoza, Xultophy 100/3.6 | Food and Beverage | In-kind items and services | $15.34 | General |
| Category: Diabetes | ||||||
| 06/13/2019 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.08 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/06/2019 | Astellas Pharma US Inc | MYRBETRIQ (Drug) | Food and Beverage | In-kind items and services | $16.75 | General |
| Category: UROLOGY | ||||||
| 05/31/2019 | GlaxoSmithKline, LLC. | ANORO (Drug) | Food and Beverage | In-kind items and services | $11.75 | General |
| Category: RESPIRATORY | ||||||
| 05/28/2019 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $15.46 | General |
| Category: Diabetes | ||||||
| 05/08/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug), INVOKANA | Food and Beverage | In-kind items and services | $13.25 | General |
| Category: Cardiovascular & Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 21 | 1,383 | 3,685 | $423,834 | $113,109 |
| 2022 | 17 | 1,362 | 4,224 | $453,696 | $115,756 |
| 2021 | 18 | 1,323 | 3,954 | $418,376 | $170,611 |
| 2020 | 21 | 1,798 | 4,152 | $473,589 | $172,366 |
Total Patients
5,866
Total Services
16,015
Medicare Billing
$571,842
Procedure Codes
77
All Medicare Procedures & Services
77 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 531 | 1,002 | $222,444 | $39,190 | 17.6% |
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 21 | 1,740 | $55,680 | $32,258 | 57.9% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 29 | 29 | $10,295 | $8,199 | 79.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 181 | 181 | $41,992 | $7,345 | 17.5% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 89 | 90 | $14,826 | $6,392 | 43.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 66 | 79 | $11,929 | $3,174 | 26.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 105 | 107 | $7,466 | $3,069 | 41.1% |
| G0179 | Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | Office | 2023 | 41 | 99 | $11,286 | $2,873 | 25.5% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 42 | 45 | $15,210 | $2,619 | 17.2% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 55 | 60 | $9,000 | $2,202 | 24.5% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 23 | 24 | $11,472 | $1,435 | 12.5% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 13 | 13 | $4,576 | $975.88 | 21.3% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 33 | 33 | $990.00 | $946.44 | 95.6% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 47 | 52 | $1,612 | $495.04 | 30.7% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2023 | 14 | 14 | $644.00 | $484.68 | 75.3% |
| 90674 | Influenza vaccine, quadrivalent derived from cell cultures, preservative and antibiotic free | Office | 2023 | 14 | 14 | $1,078 | $468.86 | 43.5% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 29 | 48 | $1,488 | $466.89 | 31.4% |
| 80305 | Testing for presence of drug, read by direct observation | Office | 2023 | 14 | 15 | $1,035 | $185.25 | 17.9% |
| 90471 | Administration of vaccine | Office | 2023 | 12 | 14 | $420.00 | $179.40 | 42.7% |
| 90472 | Administration of vaccine, each additional vaccine | Office | 2023 | 11 | 11 | $286.00 | $118.80 | 41.5% |
| 81003 | Automated urinalysis test | Office | 2023 | 13 | 15 | $105.00 | $33.00 | 31.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 503 | 1,036 | $229,992 | $38,790 | 16.9% |
| J0897 | Injection, denosumab, 1 mg | Office | 2022 | 25 | 2,220 | $71,040 | $37,961 | 53.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 207 | 207 | $48,024 | $9,772 | 20.3% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 113 | 115 | $17,887 | $7,869 | 44.0% |
About Dr. Matthew West, MD
Dr. Matthew West, MD is a Family Medicine healthcare provider based in Bartlesville, Oklahoma. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/18/2006. The National Provider Identifier (NPI) number assigned to this provider is 1508884313.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Matthew West, MD has received a total of $1,240 in payments from pharmaceutical and medical device companies, with $53.15 received in 2024. These payments were reported across 82 transactions from 17 companies. The most common payment nature is "Food and Beverage" ($1,218).
As a Medicare-enrolled provider, West has provided services to 5,866 Medicare beneficiaries, totaling 16,015 services with total Medicare billing of $571,842. Data is available for 4 years (2020–2023), covering 77 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Bartlesville, OK
- Active Since 07/18/2006
- Last Updated 06/03/2011
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1508884313
Products in Payments
- Victoza (Drug) $153.78
- MYRBETRIQ (Drug) $134.67
- Ozempic (Drug) $96.46
- FARXIGA (Drug) $91.55
- Vascepa (Drug) $86.37
- ANORO (Drug) $52.87
- JARDIANCE (Drug) $47.24
- Aimovig (Biological) $39.35
- LYRICA (Drug) $35.95
- XARELTO (Drug) $32.19
- PREVNAR 20 (Biological) $29.01
- JANUVIA (Drug) $24.01
- Myrbetriq (Drug) $23.13
- TOUJEO (Drug) $18.43
- SOLIQUA (Drug) $16.86
- GEMTESA (Drug) $16.80
- TRELEGY ELLIPTA (Drug) $15.86
- Rybelsus (Drug) $15.78
- BREZTRI (Drug) $15.45
- Tresiba (Drug) $15.34
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Bartlesville
Mark Erhardt, D.o, D.O
Family Medicine — Payments: $7,806
Family Medicine $7,806
Elizabeth Sherrock, M.d, M.D
Family Medicine — Payments: $6,925
Family Medicine $6,925
Dr. Daniel Holdman, Md, MD
Family Medicine — Payments: $5,612
Family Medicine $5,612
William Davito, D.o, D.O
Family Medicine — Payments: $4,991
Family Medicine $4,991
Michael Vaclaw, M.d, M.D
Family Medicine — Payments: $4,027
Family Medicine $4,027
Ashley Estep, Do, DO
Family Medicine — Payments: $3,276
Family Medicine $3,276